New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 16, 2013
09:48 EDTNPSP, CRIS, MGNX2014 top picks in Biopharmaceuticals/BioDefense at Wedbush
Wedbush named NPS Pharmaceuticals (NPSP), Curis (CRIS) and MacroGenics (MGNX) 2014 top picks in Biopharmaceuticals/BioDefense.
News For NPSP;CRIS;MGNX From The Last 14 Days
Check below for free stories on NPSP;CRIS;MGNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
10:00 EDTNPSPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
08:04 EDTNPSPNPS Pharmaceuticals assumed with a Buy at Canaccord
Subscribe for More Information
April 11, 2014
07:50 EDTMGNXMacroGenics management to meet with Leerink
Subscribe for More Information
April 9, 2014
16:29 EDTMGNXPoint72 reports 6.6% passive stake in MacroGenics
Subscribe for More Information
April 8, 2014
07:22 EDTCRISBiotech Industry Organization to hold a conference
Subscribe for More Information
April 7, 2014
16:14 EDTCRISCuris reports CUDC-907, CUDC-427 data
Subscribe for More Information
16:11 EDTCRISCuris, Debiopharm Group report preclinical data for Debio 0932
Curis and Debiopharm Group announced the presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research, or AACR, that demonstrated synergy between Debio 0932 and various standard of care, or SOC, agents in multiple in vitro and xenograft models of non-small cell lung cancer, or NSCLC, and renal cell carcinoma, or RCC. Debio 0932 is currently being investigated in a Phase 1/2 trial in combination with SOC agents in patients with advanced NSCLC and in a Phase 1 trial in combination with everolimus, a mTOR inhibitor, in advanced RCC patients. In a high throughput combination screen performed with six different human NSCLC cell lines, Debio 0932 demonstrated consistent synergy with microtubule and mTOR/ Akt targeting agents across all six cell lines. Additionally, Debio 0932 also showed strong synergy with everolimus in multiple patient derived and conventional RCC cell lines. Similar synergy and anti-tumor activity with Debio 0932 in combination with these agents was also demonstrated in human xenograft models of NSCLC and RCC.
April 6, 2014
16:31 EDTMGNXMacroGenics presents data demonstrating MGD007 activity in colorectal cancer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use